semaglutide diarrhea and vomiting Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, gallbladder disease, dehydration-related acute kidney injury Glucagon-like Receptor-1 agonists for obesity:

Are you ready to lose the weight and keep it off

Getting the Most From Wegovy by Watching What You Eat Knowing the foods to avoid when taking Wegovy is one of the simplest ways to reduce side effects and improve your results

Now, a new study presented at the American Diabetes Associations Scientific Session 2026 and published in the journal This study presented findings from a phase 2b randomized clinical trial called SOLSTICE to test the new oral GLP-1 medication elecoglipron

GLP-1RAs may improve endothelial cell function via anti-inflammatory and vasodilatory properties

The difference is exclusively in the salt form, the molecule that pairs with the peptide to create a stable, usable compound

That is not a regulatory opinion